S. Tuncer Et Al. , "Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience.," 50th Annual Meeting of the American-Society-of-Clinical-Oncology , vol.32, Illinois, United States Of America, 2014
Tuncer, S. Et Al. 2014. Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience.. 50th Annual Meeting of the American-Society-of-Clinical-Oncology , (Illinois, United States Of America).
Tuncer, S., Basaran, M., Tanyildiz, B., Buyukbabani, N., Basaran, G., & Dogan, O., (2014). Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience. . 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America
Tuncer, Samuray Et Al. "Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience.," 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 2014
Tuncer, Samuray Et Al. "Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience.." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America, 2014
Tuncer, S. Et Al. (2014) . "Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience.." 50th Annual Meeting of the American-Society-of-Clinical-Oncology , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Samuray Tuncer Et Al. }, title={Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience.}, congress name={50th Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Illinois}, country={United States Of America}, year={2014}}